Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers

Hypertension

Volumn 56, Issue 4, 2010, Pages 741-749

  Kenny, Louise C ^a   Broadhurst, David I ^a,b   Dunn, Warwick ^b   Brown, Marie ^b   North, Robyn A ^c   McCowan, Lesley ^d   Roberts, Claire ^f   Cooper, Garth J S ^e   Kell, Douglas B ^b   Baker, Philip N ^g  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g UNIVERSITY OF ALBERTA   (Canada)

Author keywords

biomarkers; hypertension; metabolomics; preeclampsia; screening

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METABOLOMICS; PATHOGENESIS; PLASMA; PREECLAMPSIA; PRIORITY JOURNAL; SCREENING TEST;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; MASS SPECTROMETRY; METABOLOMICS; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 77957240409     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.157297     Document Type: Article

References (38)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365: 785-799. (Pubitemid 40311367)
2. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974. (Pubitemid 350144670)
3. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683. (Pubitemid 38364626)
4. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592-1594.
5. Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, Roberts TE, Mol BW, van der Post JA, Leeflang MM, Barton PM, Hyde CJ, Gupta JK, Khan KS. Methods of prediction and prevention of preeclampsia: Systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess. 2008;12:iii-iv, 1-270.
6. Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, Lambert-Messerlian GM, Porter TF, Luthy DA, Comstock CH, Saade G, Eddleman K, Merkatz IR, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, DAlton ME. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005;106:260-267. (Pubitemid 41023261)
7. Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens. 2004;17:574-581. (Pubitemid 38844983)
8. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992-1005. (Pubitemid 44343543)
9. Goodacre R, Kell DB. Evolutionary computation for the interpretation of metabolome data. In: Harrigan GG, Goodacre R, eds. Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function. Boston, MA: Kluwer Academic Publishers; 2003:239-256.
10. Sreekumar E, Issac A, Nair S, Hariharan R, Janki MB, Arathy DS, Regu R, Mathew T, Anoop M, Niyas KP, Pillai MR. Genetic characterization of 2006-2008 isolates of chikungunya virus from kerala, south india, by whole genome sequence analysis. Virus Genes. 2010;40:14-27.
11. Oresic M, Simell S, Sysi-Aho M, Nanto-Salonen K, Seppanen-Laakso T, Parikka V, Katajamaa M, Hekkala A, Mattila I, Keskinen P, Yetukuri L, Reinikainen A, Lahde J, Suortti T, Hakalax J, Simell T, Hyoty H, Veijola R, Ilonen J, Lahesmaa R, Knip M, Simell O. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med. 2008;205:2975-2984.
12. Dunn WB, Broadhurst D, Brown M, Baker PN, Redman CW, Kenny LC, Kell DB. Metabolic profiling of serum using ultra performance liquid chromatography and the ltq-orbitrap mass spectrometry system. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;871:288-298.
13. Kenny L, Dunn W, Ellis D, Myers J, Baker P, Consortium G, Kell D. Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning. Metabolomics. 2005;1:227-234.
14. Kenny LC, Broadhurst D, Brown M, Dunn WB, Redman CW, Kell DB, Baker PN. Detection and identification of novel metabolomic biomarkers in preeclampsia. Reprod Sci. 2008;15:591-597. (Pubitemid 351877082)
15. Broadhurst DI, Kell DB. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics. 2006; 2:171-196.
16. Zelena E, Dunn WB, Broadhurst D, Francis-McIntyre S, Carroll KM, Begley P, OHagan S, Knowles JD, Halsall A, Wilson ID, Kell DB. Development of a robust and repeatable uplc-ms method for the long-term metabolomic study of human serum. Anal Chem. 2009;81: 1357-1364.
17. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, Peek MJ, Rowan JA, Walters BN. The detection, investigation and management of hypertension in pregnancy: Full consensus statement. Aust N Z J Obstet Gynaecol. 2000;40:139-155. (Pubitemid 30323584)
18. Smith CA, Want EJ, OMaille G, Abagyan R, Siuzdak G. Xcms: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78: 779-787. (Pubitemid 43228585)
19. Eriksson L, Johansson E, Kettaneh-Wold N, Wold S. Multi- and Megavariate Data Analysis: Principles and Applications. Umeå, Sweden: Umetrics Academy; 2001.
20. Wold H. Soft modelling by latent variables: the non-linear iterative partial least squares (nipals) approach. In: Gani J, ed. Perspectives in Probability and Statistics, Papers in Honour of M. S. Bartlett. London, United Kingdom: Academic Press; 1975:117-142.
21. Wold S, Trygg J, Berglund A, Antti H. Some recent developments in pls modeling. Chemometr Intell Lab Syst. 2001;58:131-150. (Pubitemid 33033284)
22. Westerhuis JA, Hoefsloot HCJ, Smit S, Vis DJ, Smilde AK, van Velzen EJJ, van Duijnhoven JPM, van Dorsten FA. Assessment of plsda cross validation. Metabolomics. 2008;4:81-89. (Pubitemid 351217591)
23. Westerhuis JA, de Jong S, Smilde AK. Direct orthogonal signal correction. Chemometr Intell Lab Syst. 2001;56:13-25. (Pubitemid 32224845)
24. van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ. Centering, scaling, and transformations: Improving the biological information content of metabolomics data. BMC Genomics. 2006; 7:142.
25. Brown M, Dunn WB, Dobson P, Patel Y, Winder CL, Francis-McIntyre S, Begley P, Carroll K, Broadhurst D, Tseng A, Swainston N, Spasic I, Goodacre R, Kell DB. Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics. Analyst. 2009; 134:1322-1332.
26. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32-35.
27. Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163:670-675.
28. Broadhurst D, Goodacre R, Jones A, Rowland JJ, Kell DB. Genetic algorithms as a method for variable selection in multiple linear regression and partial least squares regression, with applications to pyrolysis mass spectrometry. Analytica Chimica Acta. 1997;348:71-86.
29. Cavill R, Keun HC, Holmes E, Lindon JC, Nicholson JK, Ebbels TM. Genetic algorithms for simultaneous variable and sample selection in metabonomics. Bioinformatics. 2009;25:112-118.
30. Allen J, Davey HM, Broadhurst D, Heald JK, Rowland JJ, Oliver SG, Kell DB. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat Biotechnol. 2003;21: 692-696. (Pubitemid 36638098)
31. Jarvis RM, Goodacre R. Genetic algorithm optimization for preprocessing and variable selection of spectroscopic data. Bioinformatics. 2005;21:860-868. (Pubitemid 40476056)
32. Kell DB. Metabolomics and machine learning: explanatory analysis of complex metabolome data using genetic programming to produce simple, robust rules. Mol Biol Rep. 2002;29:237-241.
33. Krzanowski WJ. Principles of Multivariate Analysis: A Users Perspective. Oxford, United Kingdom: Oxford University Press; 1988.
34. Speed T. Statistical Analysis of Gene Expression Microarray Data. New York, NY: Chapman and Hall/CRC; 2003.
35. Kell DB, Oliver SG. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. Bioessays. 2004;26:99-105.
36. Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH. Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia. Prenat Diagn. 2009;29:1103-1108.
37. Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS, Gomez R, Yeo L, Conde- Agudelo A, Hassan SS. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med. 2009; 22:1021-1038.
38. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension. 2009;53: 812-818.